| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BLUEPRINT MEDICINES CORP COM | 785,000 | 23,315,000 | 12.20% | ||
| 2 | AXOGEN INC | 2,000,000 | 18,060,000 | 9.45% | ||
| 3 | ARIAD PHARMACEUTICALS INC | 1,045,000 | 14,306,000 | 7.49% | ||
| 4 | MEDGENICS INC | 1,800,000 | 10,026,000 | 5.25% | ||
| 5 | AGIOS PHARMACEUTICALS INC | 130,000 | 6,867,000 | 3.59% | ||
| 6 | FIBROGEN INC COM | 330,000 | 6,831,000 | 3.57% | ||
| 7 | Foamix Pharmaceuticals Ltd. | 630,000 | 5,834,000 | 3.05% | ||
| 8 | CARA THERAPEUTICS INC | 675,000 | 5,636,000 | 2.95% | ||
| 9 | CODEXIS INC | 1,170,000 | 5,195,000 | 2.72% | ||
| 10 | CYNAPSUS THERAPEUTICS INC | 125,000 | 5,029,000 | 2.63% | ||
| 11 | HORIZON PHARMA PLC | 275,000 | 4,986,000 | 2.61% | ||
| 12 | EAGLE PHARMACEUTICALS INC COM | 70,000 | 4,900,000 | 2.56% | ||
| 13 | IMPRIMIS PHARMACEUTICALS INC | 1,215,381 | 4,631,000 | 2.42% | ||
| 14 | GLOBAL BLOOD THERAPEUTICS IN COM | 200,000 | 4,610,000 | 2.41% | ||
| 15 | PROTALIX BIOTHERAPEUTICS INC | 8,070,000 | 4,600,000 | 2.41% | ||
| 16 | MACROGENICS INC | 145,000 | 4,337,000 | 2.27% | ||
| 17 | CHIMERIX INC | 780,000 | 4,321,000 | 2.26% | ||
| 18 | Aquinox Pharmaceuticals Inc | 310,000 | 4,142,000 | 2.17% | ||
| 19 | ADAMAS PHARMACEUTICALS INC | 250,000 | 4,103,000 | 2.15% | ||
| 20 | IMMUNOMEDICS INC | 1,200,000 | 3,900,000 | 2.04% | ||
| 21 | INOTEK PHARMACEUTICALS CORP | 400,000 | 3,792,000 | 1.98% | ||
| 22 | XENON PHARMACEUTICALS INC | 410,000 | 3,321,000 | 1.74% | ||
| 23 | PROTHENA CORP PLC | 50,000 | 2,999,000 | 1.57% | ||
| 24 | EDGE THERAPEUTICS INC | 280,000 | 2,915,000 | 1.53% | ||
| 25 | LOXO ONCOLOGY INC COM | 110,000 | 2,880,000 | 1.51% | ||
| 26 | TRILLIUM THERAPEUTICS INC | 175,000 | 2,587,000 | 1.35% | ||
| 27 | ZOGENIX INC | 220,000 | 2,515,000 | 1.32% | ||
| 28 | CYTOMX THERAPEUTICS INC COM | 160,000 | 2,509,000 | 1.31% | ||
| 29 | ULTRAGENYX PHARMACEUTICAL INC COM | 35,000 | 2,483,000 | 1.30% | ||
| 30 | PROTEOSTASIS THERAPEUTICS IN | 152,000 | 2,370,000 | 1.24% | ||
| 31 | Lion Biotechnologies | 280,000 | 2,304,000 | 1.21% | ||
| 32 | CORIUM INTERNATIONAL INC | 400,000 | 2,252,000 | 1.18% | ||
| 33 | AMARIN CORP PLC | 700,000 | 2,233,000 | 1.17% | ||
| 34 | NEURODERM LTD | 98,500 | 1,821,000 | 0.95% | ||
| 35 | Nabriva Therapeutics AG | 239,500 | 1,688,000 | 0.88% | ||
| 36 | INNOCOLL HLDGS PLC | 269,100 | 1,563,000 | 0.82% | ||
| 37 | AFFIMED N V | 430,000 | 1,195,000 | 0.63% | ||
| 38 | Intec Pharma Ltd | 175,000 | 1,029,000 | 0.54% | ||
| 39 | TENAX THERAPEUTICS INC COM | 390,000 | 905,000 | 0.47% | ||
| 40 | PORTOLA PHARMACEUTICALS INC | 35,000 | 795,000 | 0.42% | ||
| 41 | ABEONA THERAPEUTICS INC | 100,000 | 600,000 | 0.31% | ||
| 42 | AMAG PHARMACEUTICALS INC COM | 15,000 | 368,000 | 0.19% | ||
| 43 | BIOLINERX LTD | 250,000 | 288,000 | 0.15% | ||
| 44 | DEPOMED INC | 1,650 | 41,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-16-000542, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
